翻訳と辞書 |
Lexatumumab
Lexatumumab (also known as ETR2-ST01) is an experimental agonistic human monoclonal antibody against TRAIL-R2 (DR5, APO-2) undergoing clinical trials for the treatment of cancer.〔(Statement on a Nonproprietary Name adopted by the USAN Council - Lexatumumab ), ''American Medical Association''.〕 HGS-ETR2 antibodies were generated by HGS through a collaboration with Cambridge Antibody Technology.〔http://www.hgsi.com/trail-receptor-antibodies-5.html〕 == References == 〔
抄文引用元・出典: フリー百科事典『 ウィキペディア(Wikipedia)』 ■ウィキペディアで「Lexatumumab」の詳細全文を読む
スポンサード リンク
翻訳と辞書 : 翻訳のためのインターネットリソース |
Copyright(C) kotoba.ne.jp 1997-2016. All Rights Reserved.
|
|